297 related articles for article (PubMed ID: 36575843)
1. Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline.
Melrose J; Smith MM
Front Biosci (Elite Ed); 2022 Oct; 14(4):27. PubMed ID: 36575843
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Flavonoids: A Natural Scaffold with Prospects as Phytomedicines against SARS-CoV2.
Saha C; Naskar R; Chakraborty S
Mini Rev Med Chem; 2024; 24(1):39-59. PubMed ID: 37138419
[TBL] [Abstract][Full Text] [Related]
3. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2.
Vijayakumar BG; Ramesh D; Joji A; Jayachandra Prakasan J; Kannan T
Eur J Pharmacol; 2020 Nov; 886():173448. PubMed ID: 32768503
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
[TBL] [Abstract][Full Text] [Related]
5. Flavonoids derived from medicinal plants as a COVID-19 treatment.
Sopjani M; Falco F; Impellitteri F; Guarrasi V; Nguyen Thi X; Dërmaku-Sopjani M; Faggio C
Phytother Res; 2024 Mar; 38(3):1589-1609. PubMed ID: 38284138
[TBL] [Abstract][Full Text] [Related]
6. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.
Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH
Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity.
Yang JY; Ma YX; Liu Y; Peng XJ; Chen XZ
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985705
[TBL] [Abstract][Full Text] [Related]
8. A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle.
Kumar S; Paul P; Yadav P; Kaul R; Maitra SS; Jha SK; Chaari A
Comput Biol Med; 2022 Mar; 142():105231. PubMed ID: 35032740
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Drug Design and Development of Novel Synthetic Compounds with Anti-Viral Property against SARS-COV-2.
Tendulkar R; Chouhan A; Gupta A; Chaudhary A; Dubey C; Shukla S
Curr Drug Discov Technol; 2022; 19(4):e280122200663. PubMed ID: 35088672
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
11. The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline.
Melrose J
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978911
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.
Khazeei Tabari MA; Iranpanah A; Bahramsoltani R; Rahimi R
Molecules; 2021 Jun; 26(13):. PubMed ID: 34202374
[TBL] [Abstract][Full Text] [Related]
13. An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms.
Dinda B; Dinda M; Dinda S; De UC
Eur J Med Chem; 2023 Oct; 258():115629. PubMed ID: 37437351
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.
Maurya DK; Sharma D
J Biomol Struct Dyn; 2022 Jun; 40(9):3949-3964. PubMed ID: 33251972
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.
Swain SS; Singh SR; Sahoo A; Hussain T; Pati S
J Biomol Struct Dyn; 2022 Sep; 40(14):6463-6476. PubMed ID: 33583350
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Dihydrobenzofuro[3,2-b]chromenes as Potential 3CLpro Inhibitors of SARS-CoV-2: A Molecular Docking and Molecular Dynamics Study.
Gorai S; Junghare V; Kundu K; Gharui S; Kumar M; Patro BS; Nayak SK; Hazra S; Mula S
ChemMedChem; 2022 Apr; 17(8):e202100782. PubMed ID: 35112482
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review.
Jantan I; Arshad L; Septama AW; Haque MA; Mohamed-Hussein ZA; Govender NT
Phytother Res; 2023 Mar; 37(3):1036-1056. PubMed ID: 36343627
[TBL] [Abstract][Full Text] [Related]
19. Traditional herbs against COVID-19: back to old weapons to combat the new pandemic.
Al-Kuraishy HM; Al-Fakhrany OM; Elekhnawy E; Al-Gareeb AI; Alorabi M; De Waard M; Albogami SM; Batiha GE
Eur J Med Res; 2022 Sep; 27(1):186. PubMed ID: 36154838
[TBL] [Abstract][Full Text] [Related]
20. Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.
Anand AV; Balamuralikrishnan B; Kaviya M; Bharathi K; Parithathvi A; Arun M; Senthilkumar N; Velayuthaprabhu S; Saradhadevi M; Al-Dhabi NA; Arasu MV; Yatoo MI; Tiwari R; Dhama K
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
